BridgeBio Oncology Therapeutics (BBOT) Q2 2026 Earnings Report

78 Followers

BBOT Q2 2026 EPS Results

Actual EPS-$0.70

Consensus EPS-$0.56

Beat/MissMissed by -$0.14

One Year Ago EPS-$50.34

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2026

Date08/11/2026

TimeAfter Close

Conference CallTuesday, August 11, 2026

BBOT Upcoming Earnings

BridgeBio Oncology Therapeutics's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 18, 2026	2026 (Q3)	-0.69 / -	-1.03	―
Aug 11, 2026	2026 (Q2)	-0.56 / -0.70	-50.345	98.60% (+49.64)
May 12, 2026	2026 (Q1)	-0.51 / -0.53	-52.15	98.99% (+51.62)
Mar 05, 2026	2025 (Q4)	-0.63 / -0.49	0.083	-690.36% (-0.57)
Nov 12, 2025	2025 (Q3)	-0.38 / -1.03	0.099	-1140.40% (-1.13)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed